CorMedix (CRMD) EBT Margin Growth (3y) (2016 - 2025)
CorMedix (CRMD) EBT Margin Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 10.06 Mn |
| Jun 30, 2025 | 3.86 Mn |
| Mar 31, 2025 | 10.69 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 7.01 Mn |
| Dec 31, 2022 | -15.92 Mn |
| Sep 30, 2022 | -9.17 Mn |
| Jun 30, 2022 | -2.22 Mn |
| Mar 31, 2022 | -10.26 Mn |
| Dec 31, 2021 | -2.19 Mn |
| Sep 30, 2021 | -1.98 Mn |
| Jun 30, 2021 | 4.15 Mn |
| Mar 31, 2021 | 2.43 Mn |
| Dec 31, 2020 | 15,456.00 |
| Sep 30, 2020 | 596,596.00 |
| Jun 30, 2020 | -4.93 Mn |
| Mar 31, 2020 | 1.31 Mn |
| Dec 31, 2019 | 10.97 Mn |